News & Information | START In The News

October 11th, 2010

Local Leading US Phase I Cancer Center Adds Two Key Staff

South Texas Accelerated Research Therapeutics (START) has announced the addition of two key personnel to their clinical roster of medical and nursing staff.  START operates the world’s largest Phase I program for clinical trials, with sites in San Antonio and Madrid, Spain.

Dr. Drew W. Rasco joins START as a clinical investigator. Dr. Rasco is board-certified in Internal Medicine. He completed medical school in 2003 at the University of Texas Health Sciences Center in San Antonio and completed his residency in Internal Medicine at the Emory University School of Medicine in Atlanta, GA. He followed this with fellowships in Hematology and Oncology at the University of Texas Southwestern Medical Center in Dallas, TX. Dr. Rasco’s major interest is in the development of new anticancer agents, with a special interest in malignancies of the gastrointestinal-tract and lungs.

In addition to Dr. Rasco, START is pleased to announce that Isabel Jimenez, RN, MSN has joined START and will serve as the practice’s Physician Referral Coordinator. Jimenez is a critical link in the chain of communication between patients, referring physicians and START oncologists. Jimenez is responsible for fielding inquiries from patients and referring physicians from across the country regarding the requirements of clinical trials and coordinating patient visits to START for evaluation. Jimenez holds a Masters of Science in Nursing, Education and Administration from Lubbock Christian University, and has been a nurse for more than 20 years. She is fluent in both English and Spanish.